Amanta Healthcare Limited (NSE:AMANTA)

India · Delayed Price · Currency is INR

228.37

+32.33 (16.49%)

At close: Nov 12, 2026

Market Cap	8.87B +90.1%
Revenue (ttm)	3.04B +10.0%
Net Income	183.32M +37.6%
EPS	5.01 +17.9%
Shares Out	38.83M
PE Ratio	45.59
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,699,204
Open	198.24
Previous Close	196.04
Day's Range	195.14 - 235.24
52-Week Range	92.00 - 228.37
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 3, 2026

About Amanta Healthcare

Amanta Healthcare Limited operates as a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products and parenteral products in Africa, Latin America, the United Kingdom, and internationally. The company manufactures its products in three product group segments Large Volume Parenteral, Nipple Head (Single Port), SteriPort (Two Ports), and Small Volume Parenteral. Additionally, it manufactures medical devices and fluid therapy - (IV Fluid), formulations, diluents, ophthalmic, respiratory ca... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1994

Employees 460

Stock Exchange National Stock Exchange of India

Ticker Symbol AMANTA

Full Company Profile

Financial Performance

In fiscal year 2026, Amanta Healthcare's revenue was 2.88 billion, an increase of 4.78% compared to the previous year's 2.75 billion. Earnings were 148.75 million, an increase of 41.66%.

Financial Statements